FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joyce Slingerland

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Fiona Simpkins; Arlene Garcia-Soto; Joyce M Slingerland
New insights on the role of hormonal therapy in ovarian cancer.
Seth A Wander; Jianqin Wei; Dekuang Zhao; Alexandra H Besser; Nanette H Bishopric; Chad J Creighton; Feng Hong; Tan A Ince; Clara Milikowski; Andy J Minn; Joyce M Slingerland
PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy.
Candace A Gilbert; Joyce M Slingerland
Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joyce Slingerland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fiona Simpkins; Arlene Garcia-Soto; Joyce M Slingerland
New insights on the role of hormonal therapy in ovarian cancer.
Steroids 2013;78(6):530-7.
2013: Seth A Wander; Jianqin Wei; Dekuang Zhao; Alexandra H Besser; Nanette H Bishopric; Chad J Creighton; Feng Hong; Tan A Ince; Clara Milikowski; Andy J Minn; Joyce M Slingerland
PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy.
Breast cancer research and treatment 2013;138(2):369-81.
2013: Candace A Gilbert; Joyce M Slingerland
Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression.
Annual review of medicine 2013;64():45-57.
2012: Fiona Simpkins; Jun Sun; Wendy Ullmer; Roel G W Verhaak; Xiang-Xi Xu; Ji-Yeon Yang; Diana Azzam; Thiago da Silva; Candace A Gilbert; Pedro Hevia-Paez; Tan A Ince; Ellis R Levin; Yiling Lu; Gordon B Mills; Ali Pedram; Brian Rabinovich; Isildinha M Reis; Joyce M Slingerland
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(21):5911-23.
2012: Jun Sun; Wen Zhou; Kosalai Kaliappan; Zafar Nawaz; Joyce M Slingerland
ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression.
Molecular endocrinology (Baltimore, Md.) 2012;26(9):1567-77.
2012: wen simon; S Zhang; M B Resnick; V Ruiz; K Singh; Joyce M Slingerland; Y So; Steven F Moss
Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer.
Oncogene 2012;31(14):1771-80.
2012: Alberto Montero; Mark D Pegram; T Rumboldt; K Schuhwerk; Pearl Seo; Orlando Silva; Joyce M Slingerland; Catherine Welsh; S Yasir; Eli Avisar; Y E Deutsch; Claudia Diaz; E Garret-Mayer; Judith Hurley DeLeo; Merce Jorda; Leonidas G Koniaris; Stefan Gluck
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer.
Breast cancer research and treatment 2012;132(1):215-23.
2011: Stephen R Hammes; Martin J Kelly; Joyce M Slingerland
The physiology of integrated nuclear and extranuclear steroid signaling: introductory comments.
Steroids 2011;76(9):821.
2011: Yi Chen; Natalia Guggisberg; Bryan T Hennessy; Mercè Jordà; Zhenlin Ju; Edwin A Alvarez; Diana Azzam; Seth A Wander; Joyce M Slingerland
Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo.
Breast cancer research and treatment 2011;128(1):69-78.
2011: Seth A Wander; Bryan T Hennessy; Joyce M Slingerland
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.
The Journal of clinical investigation 2011;121(4):1231-41.
2011: Adena E Rosenblatt; Maria Ines Garcia; Leah Lyons; Yingqiu Xie; Carol Maiorino; Laurent Désiré; Joyce M Slingerland; Kerry L Burnstein
Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.
Endocrine-related cancer 2011;18(2):207-19.
2011: Seth A Wander; Dekuang Zhao; Joyce M Slingerland
p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(1):12-8.
2010: Christopher Lobo; LOPES GILBERTO; Odalys Baez; Aurelio Castrellon; Annapoorna Ferrell; Connie Higgins; Erin Hurley; Judith Hurley; Isildinha M Reis; Stephen Richman; Pearl Seo; Orlando Silva; Joyce M Slingerland; Keleni Tukia; Catherine Welsh; Stefan Gluck
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
Breast cancer research and treatment 2010;123(2):427-35.
2010: Nan Soon Wong; Robert A Buckman; Mark Clemons; Shailendra Verma; Susan Dent; Maureen Trudeau; Kathie Roche; John Ebos; Robert Kerbel; Gerrit E Deboer; Donald J A Sutherland; Urban Emmenegger; Joyce M Slingerland; Sandra Gardner; Kathleen I Pritchard
Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):723-30.
2009: Michelle D Larrea; Seth A Wander; Joyce M Slingerland
p27 as Jekyll and Hyde: regulation of cell cycle and cell motility.
Cell cycle (Georgetown, Tex.) 2009;8(21):3455-61.
2009: Michelle D Larrea; Feng Hong; Seth A Wander; Thiago G da Silva; David M Helfman; Deborah Lannigan; Jeffrey A Smith; Joyce M Slingerland
RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(23):9268-73.
2009: Yi Chen; Natalia Guggisberg; Merce Jorda; Ana Gonzalez-Angulo; Bryan T. J. Hennessy; Gordon B Mills; Chen-Keat Tan; Joyce M Slingerland
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3396-405.
2008: Michelle D Larrea; Jiyong Liang; Thiago Da Silva; Feng Hong; Shan H Shao; Kathy Han; D Dumont; Joyce M Slingerland
Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4.
Molecular and cellular biology 2008;28(20):6462-72.
2008: Feng Hong; Michelle D Larrea; Cheryl Doughty; David J Kwiatkowski; Rachel Squillace; Joyce M Slingerland
mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation.
Molecular cell 2008;30(6):701-11.
2008: Orlando Silva; LOPES GILBERTO; Daniel Morgenzstern; Christopher Lobo; Philomena Doliny; Edgardo S Santos; Sakher Abdullah; Umang Gautam; Isildinha M Reis; Catherine Welsh; Joyce M Slingerland; Judith Hurley DeLeo; Stefan Gluck
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer.
Clinical breast cancer 2008;8(2):162-7.
2008: Isabel M Chu; Ludger Hengst; Joyce M Slingerland
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
Nature reviews. Cancer 2008;8(4):253-67.
2007: Jun Sun; Zafar Nawaz; Joyce M Slingerland
Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 2007;21(11):2651-62.
2007: Isabel Chu; Angel Arnaout; Sophie Loiseau; Jun Sun; Arun Seth; Chris McMahon; Kathy Chun; Bryan T. J. Hennessy; Gordon B Mills; Zafar Nawaz; Joyce M Slingerland
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
The Journal of clinical investigation 2007;117(8):2205-15.
2007: Baskaran Govindarajan; James E Sligh; Bethaney J Vincent; Meiling Li; Jeffrey A Canter; Brian J Nickoloff; Richard J Rodenburg; Jan A M Smeitink; Larry Oberley; Yuping Zhang; Joyce M Slingerland; Rebecca S Arnold; David J. Lambeth; Cynthia Cohen; Lula Hilenski; Kathy K Griendling; Marta Martínez-Diez; José M Cuezva; Jack L Arbiser
Overexpression of Akt converts radial growth melanoma to vertical growth melanoma.
The Journal of clinical investigation 2007;117(3):719-29.
2007: Jiyong Liang; Shan H Shao; Zhi-Xiang Xu; Bryan T. J. Hennessy; Zhiyong Ding; Michelle Larrea; Seiji Kondo; Dan J Dumont; Jordan U Gutterman; Cheryl Lyn Walker; Joyce M Slingerland; Gordon B Mills
The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.
Nature cell biology 2007;9(2):218-24.
2007: Isabel Chu; Jun Sun; Angel Arnaout; Harriette Kahn; Wedad Hanna; Steven A Narod; Ping Sun; Cheng-Keat Tan; Ludger Hengst; Joyce M Slingerland
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
Cell 2007;128(2):281-94.
2006: Sarath C Dhananjayan; Sivapriya Ramamoorthy; Obaid Y Khan; Ayesha Ismail; Jun Sun; Joyce M Slingerland; Bert W O'Malley; Zafar Nawaz
WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors.
Molecular endocrinology (Baltimore, Md.) 2006;20(10):2343-54.
2005: Charanjit Sandhu; Michael Connor; Thomas Kislinger; Joyce M Slingerland; Andrew Emili
Global protein shotgun expression profiling of proliferating mcf-7 breast cancer cells.
Journal of proteome research 2005;4(3):674-89.
2005: Wang Sheng; Guizhi Wang; Yelina Wang; Jiyong Liang; Jianping Wen; Peng-Sheng Zheng; Yaojiong Wu; Vivian Lee; Joyce M Slingerland; Dan Dumont; Burton B Yang
The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis.
Molecular biology of the cell 2005;16(3):1330-40.
2005: Laura J Esserman; Elissa M Ozanne; Mitch Dowsett; Joyce M Slingerland
Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.
Breast cancer research : BCR 2005;7(6):R1153-8.
2005: Isabel Chu; Kimberly Blackwell; Susie Chen; Joyce M Slingerland
The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.
Cancer research 2005;65(1):18-25.
2004: A Alkarain; R Jordan; Joyce M Slingerland
p27 deregulation in breast cancer: prognostic significance and implications for therapy.
Journal of mammary gland biology and neoplasia 2004;9(1):67-80.
2004: Angel Alkarain; Joyce M Slingerland
Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer.
Breast cancer research : BCR 2004;6(1):13-21.
2003: Jiyong Liang; Joyce M Slingerland
Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.
Cell cycle (Georgetown, Tex.) 2003;2(4):339-45.
2003: Michael K Connor; Rouslan Kotchetkov; Sandrine Cariou; Ansgar Resch; Rafaella Lupetti; Richard G Beniston; Frauke Melchior; Ludger Hengst; Joyce M Slingerland
CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis.
Molecular biology of the cell 2003;14(1):201-13.
2002: Jeffrey C H Donovan; Jeffrey M Rothenstein; Joyce M Slingerland
Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest.
The Journal of biological chemistry 2002;277(44):41686-92.
2002: Jiyong Liang; Judit Zubovitz; Teresa Petrocelli; Rouslan Kotchetkov; Michael K Connor; Kathy Han; Jin-Hwa Lee; Sandra Ciarallo; Charles Catzavelos; Richard Beniston; Edmee Franssen; Joyce M Slingerland
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.
Nature medicine 2002;8(10):1153-60.
2002: Sandra Ciarallo; Venkateswaran Subramaniam; Wesley Hung; Jin-Hwa Lee; Rouslan Kotchetkov; Charanjit Sandhu; Andrea Milic; Joyce M Slingerland
Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest.
Molecular and cellular biology 2002;22(9):2993-3002.
2001: Jeffrey C H Donovan; Andrea Milic; Joyce M Slingerland
Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells.
The Journal of biological chemistry 2001;276(44):40888-95.
2001: Matthias Gstaiger; R Jordan; Megan S Lim; C Catzavelos; J Mestan; Joyce M Slingerland; Wilhelm Krek
Skp2 is oncogenic and overexpressed in human cancers.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(9):5043-8.
2001: T Petrocelli; Joyce M Slingerland
PTEN deficiency: a role in mammary carcinogenesis.
Breast cancer research : BCR 2001;3(6):356-60.
2000: Pierre O Chappuis; Linda Kapusta; Louis R Bégin; Nora Wong; Jean-Sebastien Brunet; Steven A Narod; Joyce M Slingerland; William D Foulkes
Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(24):4045-52.
2000: Charanjit Sandhu; J Donovan; N Bhattacharya; Martha R Stampfer; P Worland; Joyce M Slingerland
Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Oncogene 2000;19(47):5314-23.
2000: T Petrocelli; Joyce M Slingerland
UVB induced cell cycle checkpoints in an early stage human melanoma line, WM35.
Oncogene 2000;19(39):4480-90.
2000: Sandrine Cariou; Jeffrey C H Donovan; W M Flanagan; Andrea Milic; N Bhattacharya; Joyce M Slingerland
Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(16):9042-6.
2000: Charanjit Sandhu; D M Peehl; Joyce M Slingerland
p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells.
Cancer research 2000;60(10):2616-22.
2000: Ami Tamir; T Petrocelli; K Stetler; W Chu; J Howard; B S Croix; Joyce M Slingerland; Yaacov Ben David
Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2000;11(5):269-77.
2000: Joyce M Slingerland; M Pagano
Regulation of the cdk inhibitor p27 and its deregulation in cancer.
Journal of cellular physiology 2000;183(1):10-7.
2000: John Tsihlias; W Zhang; N Bhattacharya; M Flanagan; L Klotz; Joyce M Slingerland
Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
Oncogene 2000;19(5):670-9.
2000: J Donovan; Joyce M Slingerland
Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer.
Breast cancer research : BCR 2000;2(2):116-24.
2000: Joyce M Slingerland
Transforming growth factor-beta and breast cancer: Introduction.
Breast cancer research : BCR 2000;2(2):91.
2000: Charanjit Sandhu; Joyce M Slingerland
Deregulation of the cell cycle in cancer.
Cancer detection and prevention 2000;24(2):107-18.
1999: Charles Catzavelos; Ming Tsao; G DeBoer; N Bhattacharya; F A Shepherd; Joyce M Slingerland
Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.
Cancer research 1999;59(3):684-8.
1999: Vivi Ann Flørenes; C Lu; N Bhattacharya; Janusz Rak; C Sheehan; Joyce M Slingerland; Robert S Kerbel
Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
Oncogene 1999;18(4):1023-32.
1999: John Tsihlias; Linda Kapusta; Joyce M Slingerland
The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.
Annual review of medicine 1999;50():401-23.
1998: N Lauper; A R Beck; Sandrine Cariou; Larry Richman; Kay Hofmann; W Reith; Joyce M Slingerland; Bruno Amati
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle.
Oncogene 1998;17(20):2637-43.
1998: B St Croix; C Sheehan; Janusz Rak; Vivi Ann Flørenes; Joyce M Slingerland; Robert S Kerbel
E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
The Journal of cell biology 1998;142(2):557-71.
1998: Vivi Ann Flørenes; Gunhild M Maelandsmo; Robert S Kerbel; Joyce M Slingerland; J M Nesland; R Holm
Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
The American journal of pathology 1998;153(1):305-12.
1998: W Zhang; Linda Kapusta; Joyce M Slingerland; Laurence H Klotz
Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Cancer research 1998;58(4):619-21.
1998: RICHARD JORDAN; G Bradley; Joyce M Slingerland
Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.
The American journal of pathology 1998;152(2):585-90.
1998: John Tsihlias; Linda Kapusta; G DeBoer; I Morava-Protzner; I Zbieranowski; N Bhattacharya; G C Catzavelos; Laurence H Klotz; Joyce M Slingerland
Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
Cancer research 1998;58(3):542-8.
1998: Sandrine Cariou; Charles Catzavelos; Joyce M Slingerland
Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1.
Breast cancer research and treatment 1998;52(1-3):29-41.
1998: Joyce M Slingerland; M Pagano
Regulation of the cell cycle by the ubiquitin pathway.
Results and problems in cell differentiation 1998;22():133-47.
1997: G Radeva; T Petrocelli; E Behrend; Chungyee Leung-Hagesteijn; Jorge Filmus; Joyce M Slingerland; Shoukat Dedhar
Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression.
The Journal of biological chemistry 1997;272(21):13937-44.
1997: Charanjit Sandhu; James C Garbe; N Bhattacharya; J Daksis; C H Pan; Paul Yaswen; James Koh; Joyce M Slingerland; Martha R Stampfer
Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells.
Molecular and cellular biology 1997;17(5):2458-67.
1997: Joshua LaBaer; MD Garrett; L F Stevenson; Joyce M Slingerland; Charanjit Sandhu; H S Chou; A Fattaey; Ed Harlow
New functional activities for the p21 family of CDK inhibitors.
Genes & development 1997;11(7):847-62.
1997: Charles Catzavelos; N Bhattacharya; Yee C Ung; J A Wilson; L Roncari; Charanjit Sandhu; P Shaw; H Yeger; I Morava-Protzner; Linda Kapusta; Edmee Franssen; Kathleen I Pritchard; Joyce M Slingerland
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.
Nature medicine 1997;3(2):227-30.
1996: Vivi Ann Flørenes; N Bhattacharya; M R Bani; Yaacov Ben David; Robert S Kerbel; Joyce M Slingerland
TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
Oncogene 1996;13(11):2447-57.
1996: B St Croix; Vivi Ann Flørenes; Janusz Rak; M Flanagan; N Bhattacharya; Joyce M Slingerland; Robert S Kerbel
Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents.
Nature medicine 1996;2(11):1204-10.
1996: T Petrocelli; R Poon; Daniel J Drucker; Joyce M Slingerland; Cheryl F Rosen
UVB radiation induces p21Cip1/WAF1 and mediates G1 and S phase checkpoints.
Oncogene 1996;12(7):1387-96.
1995: Lieqi Liu; Norman Lassam; Joyce M Slingerland; D Bailey; D Cole; R Jenkins; David Hogg
Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.
Oncogene 1995;11(2):405-12.
1994: Ludger Hengst; V Dulic; Joyce M Slingerland; E Lees; Steven I Reed
A cell cycle-regulated inhibitor of cyclin-dependent kinases.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(12):5291-5.
1994: Joyce M Slingerland; Ludger Hengst; C H Pan; D Alexander; M R Stampfer; Steven I Reed
A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.
Molecular and cellular biology 1994;14(6):3683-94.
1994: Michael Lishner; Joyce M Slingerland; C Theresa; SB Sutcliffe
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Leukemia & lymphoma 1994;13(1-2):131-6.
1994: Steven I Reed; E Bailly; V Dulic; Ludger Hengst; D Resnitzky; Joyce M Slingerland
G1 control in mammalian cells.
Journal of cell science. Supplement 1994;18():69-73.
1993: Joyce M Slingerland; J R Jenkins; Samuel Benchimol
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.
The EMBO journal 1993;12(3):1029-37.
1991: Joyce M Slingerland; Samuel Benchimol
Transforming activity of mutant human p53 alleles.
Journal of cellular physiology 1991;148(3):391-5.
1991: M Lishner; Joyce M Slingerland; J Barr; Tony Panzarella; pamela degendorfer; SB Sutcliffe
Second malignant neoplasms in patients with non Hodgkin's lymphoma.
Hematological oncology 1991;9(3):169-79.
1991: Joyce M Slingerland; Mark D Minden; Samuel Benchimol
Mutation of the p53 gene in human acute myelogenous leukemia.
Blood 1991;77(7):1500-7.
1989: Joyce M Slingerland; R F Grossman; D Chamberlain; C E Tremblay
Pulmonary manifestations of tuberous sclerosis in first degree relatives.
Thorax 1989;44(3):212-4.